NCT02014571 - Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 26, 2013

Primary Completion Date

July 3, 2014

Study Completion Date

January 15, 2015

Conditions

Hepatitis C, Chronic

Interventions

DRUG

GSK2878175

Round tablets (5.0mg) given once daily repeated (to 2 days), oral dose.

DRUG

Placebo

Round tablets (5.0mg) given once daily repeated (to 2 days), oral dose visually matching GSK2878175.

Trial Locations (1)

GSK Investigational Site, San Juan